Call for Abstract Submissions

Welcome to the JADPRO Live abstract submission portal for poster presentations:

• Clinical Posters
• Industry Encore Posters
• APSHO Patient Advocacy Posters

Submissions through this portal will be reviewed and considered for poster presentation at the JADPRO Live in-person conference, being held November 14-17, 2024, at the Gaylord Texan in Grapevine, Texas.

Poster descriptions and guideline links are provided below. All submitters must:

• read the descriptions,
• view/download the submission guidelines for the type of abstract you would like to submit, and
• create an account at the bottom of the page to enter the submission portal.

You will be able to save your work and come back to complete it. Submissions must be completed by the following deadlines to be considered for poster presentation.

ABSTRACT SUBMISSION DEADLINES:
APSHO Patient Advocacy Poster abstracts: July 1, 2024
Clinical Poster abstracts: July 1, 2024*
Industry Encore Poster abstracts with posters: August 1, 2024

Clinical Posters
Abstract submission for clinical poster presentation is a member benefit for advanced practitioner (AP) professional members of the Advanced Practitioner Society for Hematology and Oncology (APSHO), providing an opportunity to present innovative, original work that is significant to the role of the advanced practitioner in oncology and hematology. Clinical posters focus on areas such as AP-led practice initiatives, educational initiatives, leadership, professional growth, clinical research, evidence-based practice, quality improvement projects and quality of care. Encore and industry-supported posters are not eligible for this category. Clinical posters from accepted abstracts will be presented by the APSHO member submitting/lead author during the conference.

RETURNING THIS YEAR!

Pre-submission feedback opportunity for Clinical Posters
Abstract submitters for clinical poster presentation may send in their abstracts for feedback by an APSHO advanced practice mentor prior to the final submission deadline. Please refer to the Clinical Poster Abstract Submission Guidelines for details.

*The deadline to send in a clinical abstract for pre-submission feedback is May 8.

Oral Poster Presentation for Clinical Posters
Five accepted clinical poster abstracts will be selected for oral poster presentation during the conference. The opportunity to indicate interest in being selected for this special session will be availalble during the submission process. Please refer to the Clinical Poster Guidelines for details.

JADPRO Live 2024 Clinical Poster Abstract Submission Guidelines

Industry Encore Posters
Industry encore posters are posters that have been previously submitted as abstracts for poster consideration, peer-reviewed, accepted, and presented at a national or international educational oncology/hematology conference within 18 months of the JADPRO Live abstract submission deadline (August 1, 2024). Encore posters are focused on providing high-level data and advanced content to conference attendees and may be submitted by original authors or industry representatives with permission. Encore posters will be presented by an author on the original abstract or designated industry representative during the conference. A fee and additional benefits apply.

NOTE: Submissions must include the original poster and the original abstract, exactly as previously presented. Please refer to the Industry Encore Poster Submission Guidelines for details. For more information regarding the encore poster opportunity, contact Jessica Tamasi, jessica.tamasi@broadcastmed.com.
Please note guideline update on additional information regarding Artificial Intelligence (AI)

JADPRO Live 2024 Industry Encore Poster Submission Guidelines - Updated

APSHO Patient Advocacy Posters
Abstract submission for APSHO Patient Advocacy Posters is open to patient advocacy organizations in partnership with patients as an opportunity to share patient-centric initiatives with advanced practitioners in oncology and hematology. Gaining a better understanding of the patient perspective on topics such as communication, education, symptom management, and support provides insight for best practice in improving the overall quality of care. Patient advocacy organizations may submit directly, and patients are also invited to submit in partnership with patient advocacy organizations. Please refer to the APSHO Patient Advocacy Poster Guidelines for details. For more information regarding the patient poster opportunity, please contact Jessica Tamasi, jessica.tamasi@broadcastmed.com.

JADPRO Live 2024 Patient Advocacy Poster Abstract Submission Guidelines

Poster Presentations
All posters will be displayed and presented at the JADPRO Live in-person conference, being held November 14-17, 2024, at the Gaylord Texan in Grapevine, Texas. In addition, registered conference attendees will have digital access to the posters during JADPRO Live and throughout the on-demand period November 20 through December 31, 2024.

Key Dates	Activity
May 8	Deadline: pre-submission review opportunity - Clinical
June	Pre-submission feedback - Clinical
July 1	Deadline: Abstract submission - Clinical and Patient Advocacy
August 1	Deadline: Abstract/poster submission - Industry Encore
August	Notifications to submitters – Clinical and Patient Advocacy**
September	Notifications to submitters – Industry Encore**
October 23	Deadline: Poster presenter tasks
November 14	Presenters display posters on site at JADPRO Live

**All correspondence will be sent to the abstract submitter.

For questions regarding abstracts and posters for JADPRO Live 2024, please contact the abstract and poster coordinator, Kelley Moore, kelley.moore@broadcastmed.com..

Accessing the Abstract Submission System
Submitters may access the abstract submission portal below. Click on 'Create Account' in the New Users area to create an account for the submission system. Once the account is created, the submitter will be able to access the abstract until the submission deadline. Submissions that are incomplete after the deadline will no longer be accessible.